The US FDA New Drug Approvals in September 2024

Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month of September 2024 The US FDA has approved a total of 7 new drugs including 4 new molecular entities and 3 biologics leading to the treatment of patients and advances in the healthcare industry The major highlighted drugs were Roche’s Tecentriq Hybreza & Ocrevus Zunovo for…

ByDipanshu DixitOctober 22, 2024

News

Roche Reports the US FDA’s Approval of Ocrevus Zunovo for Treating Relapse and Progressive Multiple Sclerosis

Shots: The US FDA has approved Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq), a twice-a-year, 10-minute SC injection, to treat relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS) The approval was supported by the pivotal P-III (OCARINA) study assessing the PK, safety, clinical & radiological efficacy of the Ocrevus SC vs IV in patients (n=236)…

ByDipanshu DixitSeptember 13, 2024

The US FDA New Drug Approvals in September 2024

Roche Reports the US FDA’s Approval of Ocrevus Zunovo for Treating Relapse and Progressive Multiple Sclerosis

Contact US

OUR INFORMATION

FOLLW US

The US FDA New Drug Approvals in September 2024

Roche Reports the US FDA’s Approval of Ocrevus Zunovo for Treating Relapse and Progressive Multiple Sclerosis

FOLLW US

Sign Up to Our Newsletter